CHARACTERISTIC OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AT THE POLYCLINIC OF ONCOLOGY, DR. SOETOMO GENERAL HOSPITAL, SURABAYA IN 2017

M. Rifqi Wiyono, Siprianus Ugroseno Yudho Bintoro, Yetti Hernaningsi

= http://dx.doi.org/10.20473/mbiom.v30i1.2020.32-39
Abstract views = 101 times | downloads = 47 times

Abstract


Background: Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm because of the reciprocal translocation of chromosome 22 to chromosome 9. In the United States, the incidence of CML is 1.9 cases per 100,000 people. Whereas in Indonesia, there is no specific national data on CML prevalence, especially regarding the clinical picture even though cancer cases reach 1.4 per 1,000 population. Objective: Evaluate the characteristics and clinical features of CML patients in Dr. Soetomo General Hospital, Surabaya. Method: This is a cross-sectional descriptive study with data on the medical records of CML patients in the 2017 period at the Dr. Soetomo General Hospital, Surabaya. The sample in this study was CML patients with positive Breakpoint Clusters Region-Abelson (BCR-ABL), having a minimum age of 18 years and equipped with epidemiological data, complete blood count data, and peripheral blood smear data. Result: Thirty-three patients met the study criteria. The sample was predominantly male, with a ratio of 1.06 : 1 to female patients with a median age of 40 years. Splenomegaly was found in 87.9% of patients. The average results of leukocyte, platelet, and hemoglobin counts were 254.58 x 103 / μL, 557 x 103 / μL, and 9.55 g / dL. From the results of peripheral blood smear obtained normochromic normocytic anisopoikilocytosis erythrocyte (57.6%), all patients had an image of increased leukocytes with blast presence in 97% of patients, and 51.5% had the image of an increase in platelets and the discovery of giant platelets in 33.3% of patients. Conclusion: The sample is predominantly male with the highest incidence at a younger age range of 21-30 years; The clinical characteristics of high leukocytosis with various stage of maturation and a tendency to develop grade 2 normocytic normochromic anemia and thrombocytosis was found in the patients.


Keywords


Characteristics; Clinical Features; Chronic Myelogenous Leukemia

Full Text:

PDF

References


Atul BM. & Hoffbrand, A.V., 2014. Haematology at a glance. London: Blackwell Sciences.

Au, W., Caguioa, P., Chuah, C., Hsu, S., Jootar, S., Kim, D., Kweon, I., O’Neil, W., Saikia, T.,

Wang, J., 2009. Chronic myeloid leukemia in Asia. International Journal of Hematology, 89(1): 14-23.

Chang, F., Qazi, R.A., Khan, M., Baloch, S., Sahito, M.M., Mir, A., 2015. Clinico hematological profile and phase distribution of chronic myeloid leukemia. Biology and Medicine, 7(5): 5–8.

Chapman, J. & Azevedo, A.M., 2019. Splenomegaly. [e-book] Treasure Island: StatPearls Publishing.

Dilihat 27 November 2019 dari https://www.ncbi.nlm.nih.gov/books/NBK430907

Entasoltan, B., Bekadja, MA., Touhami, H., Mehalhal, N., Zouaoui, Z., Mesli, N., Talbi, M., Bachiri,

A., Michallet, M., 2017. Outcome of frontline treatment with “generic” Imatinib in adult patients with chronic myeloid leukemia in Algerian Population: A multicenter study. Mediterranean Journal of Hematology and Infectious Diseases, 9(1): 6–11.

Fentie, A.M., Tadesse, F., Engidawork, E., Gebremedhin, A., 2019. Prevalence and determinants of nonadherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian’s with chronic myeloid leukemia. PLoS ONE, 14(3): 1–12.

Goldman, J., 2003. Chronic Myeloid Leukemia. Dalam: D. Provan, ed. ABC of clinical haematology.

London: BMJ Books. 19.

Höglund, M., Sandin, F., Simonsson, B., 2015. Epidemiology of chronic myeloid leukaemia: an update. Annals of Hematology, 94(2): 241–247.

Jabbour, E. & Kantarjian, H., 2018. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. American Journal of Hematology, 93(3): 442–459.

Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C.,

Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., Talpaz, M., Druker, B., 2002. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. New England Journal of Medicine, 346(9): 645–652.

Kartawan, G., Suega, K., Rena, R., 2016. Karakteristik klinis pasien chronic myeloid leukemia dengan terapi tyrosine kinase inhibitor di rumah sakit umum pusat sanglah, E-Jurnal Medika Udayana, 4(9).

Howlander, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z.,

Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.., Cronin, K.A., 2019. Cancer stat facts: leukemia - chronic myeloid leukemia (CML). Dilihat: 27 November 2019 dari https://seer.cancer.gov/statfacts/html/cmyl.html

O’Brien, S., Vose, J., Kantarjian, H., 2011. Management of hematologic malignancies. Cambridge: Cambridge University Press.

Radivoyevitch, T., Jankovic, G.M., Tiu, R.V., Saunthararajah, Y., Jackson, R.C., Hlatky, L.R., Gale, R.P., Sachs, R.K., 2014. Sex differences in the incidence of chronic myeloid leukemia, Radiation and Environmental Biophysics, 53(1): 55–63.

Rahadiyanto, K.., Liana, P., Indriani, B., 2014. Pola gambaran darah tepi pada penderita leukimia di laboratorium klinik RSUP Dr. Mohammad Hoesin Palembang. Majalah Kedokteran Sriwijaya, 46(4): 259–265.

Raharjo, B., 2018. Hubungan kadar betha2 mikroglobulin serum terhadap rasio BCR-ABL pada pasien leukemia granulositik kronik (LGK) dengan terapi tyrosin kinase inhibitor. Tesis. Surabaya: Universitas Airlangga.

Reksodiputro, A.H., Syafei, S., Prayogo, N., Karsono, B., Rinaldi, I., Rajabto, W., Mulansari, N.A., 2010. Clinical characteristics and hematologic responses to Imatinib in patients with chronic phase myeloid leukemia (CML) at Cipto Mangunkusumo Hospital. Acta medica Indonesiana, 42(1): 2–5.

Reksodiputro, A.H., Tadjoedin, H., Supandiman, I., Acang, N., Kar, A.S., Bakta, I M., Fachruddin,

A.B., Ashariati, A., Suharti, C., Rinaldi, I., Salim, N., Rajabto, W., Prayogo, N., Tobing, D.L., Syampurnawati, M., Kurnianda, J., Maryono, S., Machsoes, B.D., Syahrir, M., Prenggono, D.M., Haroen, H.K., Sari, R.M., Agustini, S., Toruan, T.L., Akbar, D.F., 2015. Epidemiology study and mutation profile of patients with chronic myeloid leukemia (CML) in Indonesia. Journal of Blood Disorders and Transfusion, 06(03): 1–13.

Rendra, M., Yaswir, R., Hanif., A. M., 2013. Gambaran laboratorium leukemia kronik di bagian Penyakit Dalam RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 2(3): 141–145.

Kemenkes RI., 2013. Riset Kesehatan Dasar 2013. Jakarta: Kementrian Kesehatan RI.

Shah, N. P. & Arceci, R. J., 2014. Chronic myeloid leukemia. New York: Bristol-Myers Squibb.

Sjoberg, B.P., Menias, C.O., Lubner, M.G., Mellnick, V.M., Pickhardt, P.J., 2018. Splenomegaly: a combined clinical and radiologic approach to the differential diagnosis. Gastroenterology Clinics of North America, 47(3): 643–666.

Sumantri, A. F., Oehadian, A., Wijaya, I., Vidyaniati, P., Rahmaniati, R., 2019. Therapeutic responses of imatinib and nilotinib among CML patients in Hasan Sadikin Hospital Bandung. Indonesian Journal of Cancer, 12(3): 88.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Majalah Biomorfologi

Creative Commons License
Majalah Biomorfologi (p-ISSN:0215-8833; e-ISSN:2716-0920) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 

View Majalah Biomorfologi Statistics

 

 Indexed By